Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Editas Medicine, Inc. (EDIT) vs Prothena Corporation plc (PRTA)

Editas Medicine, Inc. and Prothena Corporation plc are both Biotechnology companies. Editas Medicine, Inc. and Prothena Corporation plc are of similar size ($430.0M and $427.1M). Prothena Corporation plc grew revenue faster over the last twelve months: 427.3% against 20.8%. Prothena Corporation plc has the higher net margin (−80.7% vs −157.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Prothena Corporation plc leads on 11 and Editas Medicine, Inc. on 4.

Valuation

Metric EDIT PRTA Biotechnology median
P/E n/m n/m 7.88
P/S 6.55 7.93 11.47
P/B 2.92 1.51 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 2.58 2.64 10.73
Earnings yield (29.07%) (10.01%) (28.84%)
Free cash flow yield (39.08%) (14.06%) (23.03%)

Profitability

Metric EDIT PRTA Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (161.39%) (101.80%) 0.00%
Net margin (157.32%) (80.67%) 0.00%
Free cash flow margin (255.88%) (111.49%) 0.00%
Return on equity (118.82%) (14.39%) (57.72%)
Return on assets (33.02%) (12.54%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EDIT PRTA Biotechnology median
Revenue growth (TTM) 20.83% 427.32% 5.64%
EPS growth (last fiscal year) 37.50% (99.56%) —
Revenue growth, 5-year CAGR (14.89%) 62.56% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EDIT PRTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.19 25.05 4.73
Net debt to EBITDA 0.94 1.46 0.96

Dividend

Metric EDIT PRTA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric EDIT PRTA Biotechnology median
Market cap 430.03m 427.12m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack